| Target Price | kr32.64 |
| Price | kr23.05 |
| Potential |
41.61%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Genovis 2026 .
The average Genovis target price is kr32.64.
This is
41.61%
register free of charge
kr51.45
123.21%
register free of charge
kr32.32
40.22%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Genovis to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Genovis stock has an average upside potential 2026 of
41.61%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million kr | 130.36 | 138.72 |
| 17.61% | 6.41% | |
| EBITDA Margin | 30.60% | 30.88% |
| 25.05% | 0.92% | |
| Net Margin | 25.25% | 18.05% |
| 35.03% | 28.52% |
4 Analysts have issued a sales forecast Genovis 2025 . The average Genovis sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Genovis EBITDA forecast 2025. The average Genovis EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Genovis Analysts have issued a net profit forecast 2025. The average Genovis net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 0.50 | 0.38 |
| 46.81% | 24.00% | |
| P/E | 60.26 | |
| EV/Sales | 10.03 |
4 Analysts have issued a Genovis forecast for earnings per share. The average Genovis EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


